Charter Communications, Inc. (CHTR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHARTER COMMUNICATIONS, INC. (CHTR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Happened?
On July 25, 2025, Charter released its second quarter 2025 financial results, reporting that total internet customers had declined by 117,000, compared to about 100,000 in the second quarter of 2024, when adjusted to remove the prior year's impact of ACP related disconnected. The Company's total video customers also decreased by 80,000.
On this news, Charter's stock price fell $70.25, or 18.5%, to close at $309.75 per share on July 25, 2025, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Charter securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
8 minutes ago
- Globe and Mail
Paramount Global Reports Strong Q2 2025 Earnings
Paramount Global ( (PARA)) has released its Q2 earnings. Here is a breakdown of the information Paramount Global presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Paramount Global is a leading global media and entertainment company known for its extensive portfolio of iconic brands, including CBS, Paramount Pictures, and Paramount+, offering a wide range of content and streaming services. In its latest earnings report for Q2 2025, Paramount Global highlighted its continued transformation into a streaming-first company, with direct-to-consumer (DTC) revenue growing by 15% year-over-year, driven by the strong performance of Paramount+. The company's total revenue increased by 1% compared to the previous year, with notable growth in affiliate and subscription revenue. Paramount+ saw a 23% increase in total revenue and a 24% rise in subscription revenue, reflecting improved watch time and reduced churn. Despite a 6% decline in TV media revenue, the company achieved significant milestones in its content offerings, with CBS maintaining its position as the most-watched broadcast network in primetime for the 17th consecutive season. Paramount Pictures also reported a successful quarter, with the global premiere of 'Mission: Impossible – The Final Reckoning' setting a franchise record for the biggest global opening. Looking ahead, Paramount Global's management remains optimistic about the company's growth prospects, emphasizing the strength of its content strategy and the ongoing expansion of its streaming services.
Globe and Mail
an hour ago
- Globe and Mail
Comcast Reports Strong Q2 2025 Earnings Growth
Comcast Corp ( (CMCSA)) has released its Q2 earnings. Here is a breakdown of the information Comcast Corp presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Comcast Corporation is a global media and technology company that provides broadband, wireless, and video services through brands like Xfinity and Sky, and produces and distributes content via NBC, Universal, and Peacock, among others. In its second-quarter earnings report for 2025, Comcast Corporation announced a 2.1% increase in revenue to $30.3 billion and a significant rise in net income attributable to Comcast to $11.1 billion, largely due to a $9.4 billion gain from the sale of its interest in Hulu. The company also reported a 3.3% increase in adjusted earnings per share to $1.25 and generated $4.5 billion in free cash flow. Comcast's wireless business achieved record growth, adding 378,000 lines, and its theme parks segment saw a revenue increase of 18.9%, driven by the opening of Epic Universe. The company's media segment also performed well, with Peacock revenue up 18%. Despite a decrease in adjusted net income by 1.7%, Comcast returned $2.9 billion to shareholders through dividends and share repurchases. Looking ahead, Comcast remains confident in its strategic focus and capital allocation, positioning itself well for future growth with plans to expand its content offerings, including NBA coverage on Peacock.
Globe and Mail
an hour ago
- Globe and Mail
AbbVie Reports Strong Q2 2025 Financial Results
Abbvie ( (ABBV)) has released its Q2 earnings. Here is a breakdown of the information Abbvie presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AbbVie Inc. is a global biopharmaceutical company that focuses on discovering and delivering innovative medicines in key therapeutic areas such as immunology, neuroscience, oncology, and eye care, alongside its Allergan Aesthetics portfolio. In the second quarter of 2025, AbbVie reported a strong financial performance with an increase in net revenues and adjusted earnings per share, highlighting the company's diversified growth platform and strategic investments in innovation. Key financial metrics from the quarter include a 6.6% increase in net revenues to $15.423 billion, driven by significant growth in the immunology and neuroscience portfolios. Skyrizi and Rinvoq showed substantial revenue increases of 62.2% and 41.8%, respectively, while the neuroscience portfolio grew by 24.2%. However, the aesthetics portfolio saw a decline of 8.1% in revenues. AbbVie also announced several strategic advancements, including FDA approvals for new treatments and positive clinical trial results, which bolster its pipeline and future growth prospects. The company has raised its full-year 2025 adjusted diluted EPS guidance, reflecting confidence in continued momentum. Looking ahead, AbbVie remains optimistic about its growth trajectory, supported by its robust pipeline and strategic initiatives, as it continues to focus on delivering innovative solutions to address significant health challenges.
